- Diebold Nixdorf Inc DBD shares gained over 22% in premarket trading on March 22 after it confirmed closing on $55 million additional liquidity.
- On March 21, Diebold Nixdorf amended its asset-based credit facility (ABL) to add a new $55 million first-in-last-out term loan (FILO) tranche.
- Additionally, Diebold Nixdorf's ABL lenders have agreed to certain other modifications and waivers to the ABL facility, allowing them to continue working together to develop an updated borrowing framework.
- The existing $250 million non-FILO ABL tranche commitments remain in place.
- Diebold Nixdorf recently reported $3.46 billion in revenue in 2022 and entered 2023 with a backlog of approximately $1.47 billion – demonstrating strong demand for its Banking and Retail solutions, specifically ATMs and ATMs self-checkout (SCO) products.
- ATM and SCO shipments will likely increase in the first half of 2023 by approximately 14% Y/Y and 51% Y/Y.
- It expects a 2023 Q1 revenue of approximately $835 million, up by 6% Y/Y.
- Price Action: DBD shares traded higher by 23.5% at $0.98 premarket on the last check Wednesday.
Loading...
Loading...
DBDDiebold Nixdorf Inc
$59.320.54%
Edge Rankings
Momentum
89.75
Growth
76.42
Quality
Not Available
Value
37.99
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
